Interdisciplinary multimodality management of stage III nonsmall cell lung cancer

Rudolf M. Huber, Dirk De Ruysscher, Hans Hoffmann, Simone Reu, Amanda Tufman

Source: Eur Respir Rev, 28 (152) 190024; 10.1183/16000617.0024-2019
Journal Issue: June
Disease area: Thoracic oncology

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Rudolf M. Huber, Dirk De Ruysscher, Hans Hoffmann, Simone Reu, Amanda Tufman. Interdisciplinary multimodality management of stage III nonsmall cell lung cancer. Eur Respir Rev, 28 (152) 190024; 10.1183/16000617.0024-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1119-1133
Year: 2013



Management of stage I and II nonsmall cell lung cancer
Source: Eur Respir J 2017; 49(1): 1600764; DOI: 10.1183/13993003.00764-2016
Year: 2017




Multimodality management of non-small cell lung cancer stage III: the pulmonologist as pilot and partner
Source: Virtual Congress 2021 – Thoracic oncology
Year: 2021


Imaging for staging stage III nonsmall cell lung cancer
Source: ISSN=ISSN 1810-6838, ISBN=, page=47
Year: 2007

Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Radiotherapy with curative intent for stage I and II non-small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Management of locally advanced nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 260–270
Year: 2009

International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?
Source: ERJ Open Res, 6 (1) 00159-2019; 10.1183/23120541.00159-2019
Year: 2020



Radiotherapy for stage III non-small cell lung cancer (NSCLC)
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

New treatment concepts in stage IV non-small cell lung cancer: personalised multidisciplinary approaches
Source: Virtual Congress 2021 – Thoracic oncology
Year: 2021


First- and second-line therapy for advanced nonsmall cell lung cancer
Source: Eur Respir J 2009; 33: 915-930
Year: 2009



Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Source: ERS webinar 2021: Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Year: 2021


Adjuvant chemotherapy in stage Ib of non-small cell lung cancer (NSCLC)-experience of a pneumology department
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

The treatment of stage IV non-small cell lung cancer with target therapies
Source: Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC?
Year: 2013


Survival impact of surgery in the treatment of stage IIIB-IVA non-small cell lung cancer
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018


Adjuvant chemotherapy in stage IB nonsmall cell lung cancer
Source: Breathe 2009; 5: 361
Year: 2009

The method of individualisation of treatment and prognosis for advanced non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010